Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.53 |
| ▸ | ST14 | Q9Y5Y6 | 4/20 | 0.53 |
| ▸ | PLAU | P00749 | 2/20 | 0.53 |
| ▸ | PRSS1 | P07477 | 9/20 | 0.53 |
| ▸ | TMPRSS2 | O15393 | 2/20 | 0.52 |
| ▸ | PRMT1 | Q99873 | 3/20 | 0.50 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.50 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.50 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.50 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.50 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.50 |
| ▸ | PTP4A3 | O75365 | 1/20 | 0.50 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.50 |
| ▸ | F10 | P00742 | 1/20 | 0.50 |
| ▸ | PLG | P00747 | 1/20 | 0.50 |
| ▸ | S100B | P04271 | 1/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.50 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28216941 | 0.85 | PARP10 (0.57) | — | |
| SCHEMBL11767220 | 0.84 | ESR1 (0.66) | F2ST14PLAUPRSS1TMPRSS2 | |
| SCHEMBL8905138 | 0.82 | PRSS1 (0.50) | F2ST14PLAUPRSS1TMPRSS2 | |
| SCHEMBL4587308 | 0.81 | HSD17B10 (0.52) | — | |
| Hydrochloric Acid SCHEMBL8500971 | 0.81 | PRSS1 (0.51) | F2ST14PLAUPRSS1TMPRSS2 | |
| SCHEMBL8503419 | 0.81 | PRSS1 (0.51) | F2ST14PLAUPRSS1TMPRSS2 | |
| Hydrochloric Acid SCHEMBL8497832 | 0.80 | PRSS1 (0.53) | F2ST14PLAUPRSS1TMPRSS2 | |
| SCHEMBL10593101 | 0.79 | KMT2A (0.57) | — | |
| SCHEMBL27500022 | 0.77 | PRSS1 (0.59) | F2ST14PLAUPRSS1TMPRSS2 | |
| SCHEMBL5973253 | 0.76 | KMT2A (0.43) | F2PLAUPRSS1TMPRSS2PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102584940-B | Peptidic compounds | UNIV WOLLONGONG | 2014-12-31 | — | — | CN | disclosed |
| CN-102584939-B | Peptidic compounds | UNIV WOLLONGONG | 2014-08-06 | — | — | CN | disclosed |
| CN-101142175-B | Peptide compounds | UNIV WOLLONGONG | 2013-03-06 | — | — | CN | disclosed |
| US-7407982-B2 | Oligo or polyalkylene glycol-coupled thrombin inhibitors | HAEMOSYS GMBH (DE) | 2008-08-05 | — | — | US | disclosed |
| US-20050070479-A1 | Oligo or polyalkylene glycol-coupled thrombin inhibitors | HAEMOSYS GMBH (DE) | 2005-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050070479-A1 | Oligo or polyalkylene glycol-coupled thrombin inhibitors | TFPI, SERPINC1, PLG | F2 5/4885ST14 125/4885PLAU 39/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.